)
CorMedix (CRMD) investor relations material
CorMedix AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting called to order virtually, with introductions of executive officers and board members.
Procedural matters and formal business to be conducted, with voting on eight proposals.
Shareholder proposals
Eight proposals presented: election of directors, executive compensation, auditor ratification, certificate of designation amendments, technical charter changes, preferred stock amendment process, exclusive forum designation, and officer liability limitation.
Overview of voting outcomes
All seven director nominees elected to the board.
Executive compensation for 2025 approved on a non-binding advisory basis.
Appointment of CBIZ CPAs as independent auditor for 2026 ratified.
Proposals on certificate of designation amendments, technical charter changes, preferred stock amendment process, exclusive forum designation, and officer liability limitation all failed to receive necessary votes.
Final voting results to be filed on Form 8-K with the SEC within four business days.
- First profitable quarter: $39.1M revenue, $20.6M net income, H1 guidance at $70M.CRMD
Q1 20259 Jul 2026 - Diversified portfolio and robust pipeline drive growth, targeting major unmet needs in anti-infectives.CRMD
Investor Day 20269 Jul 2026 - DefenCath launch drove $11.5M Q3 revenue, strong margins, and expanded US dialysis access.CRMD
Q3 20248 Jul 2026 - Q3 2025 net income hit $108.6M on strong sales and Melinta integration, with raised FY guidance.CRMD
Q3 20258 Jul 2026 - 2026 guidance reflects a transitional year as pipeline assets and new markets drive future growth.CRMD
44th Annual J.P. Morgan Healthcare Conference8 Jul 2026 - Diversified portfolio, pipeline progress, and reimbursement shifts set stage for future growth.CRMD
Jefferies Global Healthcare Conference 20263 Jun 2026 - Strong growth driven by DefenCath, REZZAYO, and pipeline expansion in institutional markets.CRMD
Corporate presentation24 May 2026 - REZZAYO advances toward broader approval as DefenCath guidance and reimbursement outlook improve.CRMD
RBC Capital Markets Global Healthcare Conference 202620 May 2026 - Q1 2026 revenue and profit surged, guidance was raised, and pipeline progress accelerated.CRMD
Q1 202614 May 2026
Next CorMedix earnings date
Next CorMedix earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)